We analyzed mutation data of the breast cancer samples with and without “pathogenic” or “likely pathogenic” BRCA1 mutation as determined by ACMG 2015 criteria (referred to as BRCA1-positive and -negative, respectively) that were available on three public cancer databases: TCGA, ICGC, and COSMIC). This evidence concerns the gene BRCA1 and breast carcinoma.